Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer.
bladder cancer
clinical biomarkers
genomic instability signature
non-coding mutation
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
08 Oct 2020
08 Oct 2020
Historique:
received:
24
09
2020
revised:
01
10
2020
accepted:
03
10
2020
entrez:
14
10
2020
pubmed:
15
10
2020
medline:
15
10
2020
Statut:
epublish
Résumé
Numerous pan-genomic studies identified alterations in protein-coding genes and signaling pathways involved in bladder carcinogenesis, while non-coding somatic alterations remain weakly explored. The goal of this study was to identify clinical biomarkers in non-coding regions for bladder cancer patients. We have previously identified in bladder tumors two non-coding mutational hotspots occurring at high frequencies (≥30%). These mutations are located close to the
Identifiants
pubmed: 33049910
pii: cancers12102882
doi: 10.3390/cancers12102882
pmc: PMC7650671
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Urol. 2006 May;175(5):1915-20
pubmed: 16600798
BMC Genomics. 2017 Jan 5;18(1):17
pubmed: 28056774
Int J Cancer. 2003 Sep 20;106(5):758-65
pubmed: 12866037
Mol Cancer Res. 2019 Feb;17(2):469-475
pubmed: 30401719
Nat Genet. 2014 Nov;46(11):1160-5
pubmed: 25261935
Cancer Discov. 2019 Apr;9(4):500-509
pubmed: 30578357
J Clin Oncol. 2019 Jun 20;37(18):1547-1557
pubmed: 31059311
Nature. 2014 Mar 20;507(7492):315-22
pubmed: 24476821
Investig Clin Urol. 2016 Jun;57 Suppl 1:S60-76
pubmed: 27326409
Eur Urol. 2015 Aug;68(2):238-53
pubmed: 25709027
Nature. 2020 Feb;578(7793):102-111
pubmed: 32025015
Cell Rep. 2014 Jun 26;7(6):1833-41
pubmed: 24910434
Oncol Lett. 2019 Oct;18(4):3471-3480
pubmed: 31516565
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
Nat Genet. 2016 May;48(5):500-9
pubmed: 27064257
Eur Urol. 2017 Jan;71(1):96-108
pubmed: 27370177
Ann Oncol. 2014 Sep;25 Suppl 3:iii40-8
pubmed: 25096609
Oncoimmunology. 2019 Mar 16;8(5):e1581556
pubmed: 31069145
Mol Diagn Ther. 2019 Oct;23(5):579-601
pubmed: 31325035
J Clin Oncol. 2020 Jan 1;38(1):1-10
pubmed: 31682550
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17426-31
pubmed: 24101484
Cell Rep. 2019 Mar 5;26(10):2651-2666.e6
pubmed: 30840888
Nature. 2017 Jul 6;547(7661):55-60
pubmed: 28658208
Nature. 2015 Oct 22;526(7574):519-24
pubmed: 26200345
World J Urol. 2019 Jan;37(1):31-40
pubmed: 30259123
Science. 2019 Jun 28;364(6447):
pubmed: 31249028
Nat Genet. 2019 Feb;51(2):202-206
pubmed: 30643254